posted on Apr, 3 2006 @ 10:18 PM
You may call it the source of the 'anti-munchies.' Sanofi-Aventis is in the final stages of gaining approval of a dietary pill that is an
antagonist (blocker) of cannabinoid receptors (the one marijuana works on). The chemical name of the pill is called rimonabant and it will be
marketed as ''Acomplia.''
Studies in toxicity have shown it to be safe.
I can't help but wonder if it will have effects on learning and memory.
What is interesting is that this is simply an antagonist (blocker) and not an inverse agonist (activator that does the opposite of marijuana).
What think you ladies and gentlemen?